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Abstract
Objectives: Stent implantation for the treatment of aortic coarctation has become a standard approach for the
management of older children and adults. Criteria for optimal stent design and construction remain undefined. This
study used computational modelling to compare the performance of two generations of the Cheatham-Platinum stent
(NuMED, Hopkinton, NY, USA) deployed in aortic coarctation using finite element analysis.
Design: Three-dimensional models of both stents, reverse engineered from microCT scans, were implanted in the
aortic model of one representative patient. They were virtually expanded in the vessel with a 16mm balloon and a
pressure of 2 atm.
Results: The conventional stent foreshortened to 96.5% of its initial length, whereas the new stent to 99.2% of its initial
length. Diameters in 15 slices across the conventional stent were 11.6–15mm (median 14.2mm) and slightly higher
across the new stent: 10.7–15.3mm (median 14.5mm) (p¼ 0.021). Apposition to the vessel wall was similar: conven-
tional stent 31.1% and new stent 28.6% of total stent area.
Conclusions: The new design Cheatham-Platinum stent showed similar deployment results compared to the conventional
design. The new stent design showed slightly higher expansion, using the same delivery balloon. Patient-specific computational
models can be used for virtual implantation of new aortic stents and promise to inform subsequent in vivo trials.
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Introduction
Stent implantation for the treatment of (re-)coarctation
of the aorta (CoA) has become a standard approach
for the management of older children and adults.
Although the indications and methods have been
well discussed, the criteria for optimal stent design
and construction remain undefined. Most stents used
for the CoA treatment were designed for other uses.
We used computational modelling of CoA stenting in
the design process of a modified version of the
Cheatham-Platinum (CP) stent (NuMED, Hopkinton,
NY, USA).
A modified CP stent was manufactured with the aim
to improve foreshortening when deployed at higher
diameters. Before clinical testing, we wished to ensure
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the modifications made to the stent were not detrimen-
tal to its behaviour over the normal operating range.
Patient-specific modelling with a conventional CP
stent has been described for a patient who then under-
went CoA stenting.1 Deployment of known stents has
been simulated for coronary bifurcations.2 The aim of
our study was to assess deployment of a conventional
versus a modified CP stent by biomechanical simula-
tion in a virtual CoA environment prior to clini-
cal testing.
Methods
Stent properties
The standard CP stent has a closed cell design and is
formed of gold welded rows of bent platinum-iridium
alloy wires. Eight bends are made in each crown to
achieve a compromise of expansion potential with min-
imal deployment profile. This allows a large maximal
diameter (22mm) and good radial strength, but also
foreshortening at higher diameters and increased frac-
ture risk when subjected to significant repetitive
mechanical stress.3 The closed cell design causes fore-
shortening of up to 40% at the top end of the expan-
sion range. The new CP stent is a prototype with the
same material properties, but with a new configuration
designed to limit shortening behaviour. Micro-
computed tomographies (CTs) of the conventional
and the modified CP stents were obtained for model-
ling. The same material property assumptions were
made for both stents, neglecting the welding material
with its small volume and lower stiffness.
Aortic model
A preinterventional CT was performed per clinical
indication on GE Lightspeed Volume CT, slice thick-
ness 0.625mm, prospectively acquired in mid-diastole.
The relevant ethics committee waived informed consent
for further use of the images. This was a proof of con-
cept study using a patient-based rather than an artifi-
cial virtual environment, without interventions in
humans. Only one set of patient data was used to
create the virtual environment for stent testing at this
time, analogous to conventional bench testing of new
stent designs in one artificial virtual environment.
Patient data were chosen based on the following crite-
ria: adult, aortic coarctation in the typical location just
distal to the left subclavian artery origin and good
quality CT scan. DICOM data from the aortic and
stent CTs were imported into the virtual environment.
The distal end of the aortic model was chosen to be
approximately 5 cm below the prospective distal end of
the stent to ensure that boundary conditions did not
influence implantation.
Simulation of stent delivery
First, plastic deformations were induced in the bends of
each stent by expanding it with a rigid cylinder
to 33mm (nominal diameter x2). Next, the stent was
Figure 1. Stent deployment into the aortic isthmus in the virtual environment. (a) A guidewire with the stent crimped on a balloon,
placed over an approximate aortic centreline; (b) the guidewire is relaxed inside the vessel to obtain a natural configuration of the
delivery system; (c) balloon inflation; (d) the final configuration of the stent.
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crimped on a 50mm balloon to a diameter of 3.1mm
(see Figure 1).
The compliance chart of a BIB balloon (NuMED,
Hopkinton, NY, USA) was used for balloon model
calibration, considering only the outer, 16mm balloon
which influences the final, expanded shape of the stent.
The delivery system was then overlaid within the
aortic model, with the centre of the stent at the site of
the most severe stenosis. A guidewire modelled with the
properties of a stiff polymer was bent over the approxi-
mate centre line of the aorta. The guidewire was then
relaxed inside the vessel to obtain a natural configuration
of the delivery system, and to take into account the
forces and deformations induced by the delivery system
on the aorta prior to balloon expansion.
Finally, the virtual balloon was fully inflated with a
pressure of 2 atm, as had been done in the clini-
cal procedure.
Measurements
Foreshortening was measured as the post-implantation
stent length as a percentage of the initial stent length.
The proportion of apposed (<0.5mm between outer
strut surface and inner aortic surface) surface area was
measured for each stent, ignoring the thin gold layer.
Stent diameters in 15 equally distributed slices were
calculated as the twofold mean radius between the cal-
culated centre of the cross-sectional area and the struts.
A Wilcoxon signed-rank test was applied to examine
for differences in the resulting stent diameters. Figure 2
shows the cross-sectional slices in the virtual model and
a reconstruction of the post-implantation CT.
An elastoplastic material was used for calibration of
vessel properties. Arterial maximum principal
logarithmic strain was measured and overlaid as
colour maps on the aortic model.
Results
The conventional stent foreshortened from 43.5 to
42.0mm (96.5%) and was apposed over 31.1% of its
outer area. The new stent foreshortened from 51.4 to
50.9mm (99.2%), and apposition covered 28.6% of
its area.
While malapposition of the stent in the stenotic area
would have been undesirable, both stents were malap-
posed at the left subclavian artery origin (old stent:
Figure 2. Cross-sectional slices in the virtual model (left) and a reconstruction of the post-implantation CT (right).
Table 1. Diameters of the conventional and the modified stent
at full inflation at regular intervals along the length of each stent.
Slice number
Conventional stent
diameter (mm)
New stent
diameter (mm)
S1 (proximal) 15.0 15.1
S2 14.5 14.9
S3 14.2 14.5
S4 13.8 13.9
S5 13.2 13.2
S6 12.2 12.1
S7 11.6 10.7
S8 11.7 12.0
S9 12.9 13.2
S10 13.6 14.2
S11 14.2 14.5
S12 14.3 14.7
S13 14.5 15.0
S14 14.6 15.1
S15 (distal) 15.0 15.3
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S2-S6, new stent: S3-S6), which may positively affect
flow into that artery.
Table 1 shows the post-implantation diameters of
both stents. Diameters in 15 slices across the conven-
tional stent were 11.6–15.0mm (median 14.2mm) and
slightly higher across the new stent: 10.7–15.3mm
(median 14.5mm) (p¼<0.05).
Both stents led to deformation of the aortic wall
only in the areas of good apposition and the immedi-
ately adjacent areas (i.e. the caudal aspect of the prox-
imal left subclavian artery), which is the desired effect
of the intervention to increase the vessel diameter at the
stenosis (Figure 3).
Discussion
To our knowledge, this is the first description of a
patient-specific computational model to examine the
properties of two different stents during implantation
and their effects on the vessel wall. The standard
method for virtual bench testing involves an idealised
geometrical model of the target vessel.4 However, with
the availability of high-resolution three-dimensional
cardiovascular imaging, models can be made to
mirror real-life anatomy.
The conventional CP stent is widely used, and this
modelling method was chosen for a preliminary evalu-
ation of a stent modification. The key objective was to
ensure that the modifications did not adversely affect
the expansion and foreshortening behaviour or aortic
wall strain.
Arterial strain is an important immediate stent
implantation endpoint, determining the resultant diam-
eter of the stenosis after treatment, and can be mea-
sured by finite element analysis.5 Both stents resulted in
similarly high aortic wall strain. Future virtual trials
should include testing on known weak spots in the
vessel wall (e.g. stent implantations that led to aortic
wall dissections or aneurysms) to assess how much
strain the new stent would have induced in that fragile
tissue.
Due to reduced foreshortening, the new stent may
have benefitted from a longer balloon to achieve
even better apposition. Future models could com-
pare stent apposition in diastole versus systole,
using dual-phase 3D images as an anatomi-
cal scenario.
Figure 3. Aortic wall strain in the same area by the conventional (top) and the new stent (bottom).
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Limitations
Proprietary information about the stents was not avail-
able, and they had to be reverse engineered for 3D
modelling, which may have introduced minor geomet-
rical inaccuracies.
Different aortic configurations may be more amena-
ble to stenting with the previous versus the new gener-
ation CP stent or vice versa, which was not investigated
in this study.
This study cannot answer the question of stent
recoil, because the true aortic tissue material properties
were unknown.
Conclusion
The conventional and the new CP stents deform
and appose themselves to the CoA similarly.
Computational modelling of reverse engineered stents
in models derived from actual implantations can be
used for comparison of different stent designs.
Computational modelling allows ‘virtual pre-clinical
trials’ based on 3D imaging for the evaluation of new
implantable cardiovascular devices and will facilitate
informed decisions about sample sizes for clini-
cal evaluation.
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